Reelevation of Parathyroid Hormone Level After Parathyroidectomy in Patients with Primary Hyperparathyroidism: Importance of Decreased Renal Parathyroid Hormone Sensitivity
Overview
Authors
Affiliations
Background: We hypothesized that impaired peripheral sensitivity to parathyroid hormone (PTH) may play a role in reelevation of PTH after successful operation for primary hyperparathyroidism (pHPT).
Methods: Factors affecting reelevation of PTH were determined in 90 patients who underwent parathyroidectomy for pHPT. PTH/nephrogenous cyclic adenosine monophosphate ratio, as an index of renal resistance to PTH, was examined in relation to factors shown to influence reelevation of PTH.
Results: Serum PTH levels were elevated above the upper limit of normal in 23 patients (26%) at 1 week and in 39 patients (43%) at 1 month after parathyroidectomy. These 39 normocalcemic patients with elevated serum PTH at 1 month after parathyroidectomy had a higher preoperative serum level of PTH and lower serum phosphate and 25-hydroxyvitamin D (25OHD) concentrations than those with normal PTH (n = 59). Elevated PTH and low 25OHD were shown by multivariate analysis to be significant predictors of reelevation of PTH. Renal resistance to PTH was higher in patients with vitamin D deficiency or renal insufficiency than in patients with normal serum vitamin D concentrations or normal renal function, and it increased according to increases in levels of PTH.
Conclusions: The mechanism of PTH reelevation in patients with pHPT after successful parathyroidectomy appears to be renal resistance to PTH.
Uludag M, Unlu M, Kostek M, Caliskan O, Aygun N, Isgor A Sisli Etfal Hastan Tıp Bul. 2023; 57(1):1-17.
PMID: 37064844 PMC: 10098391. DOI: 10.14744/SEMB.2023.39260.
Shao Y, Zeng Q, Lv B, Chen X, Sheng L Front Surg. 2022; 9:893259.
PMID: 35711701 PMC: 9193965. DOI: 10.3389/fsurg.2022.893259.
Persistent Elevation of Parathormone Levels after Surgery for Primary Hyperparathyroidism.
Kota S, Kota S, Jammula S, Bhargav P, Sahoo A, Das S Indian J Endocrinol Metab. 2020; 24(4):366-372.
PMID: 33088762 PMC: 7540826. DOI: 10.4103/ijem.IJEM_212_20.
Caldwell M, Laux J, Clark M, Kim L, Rubin J J Clin Endocrinol Metab. 2019; 104(10):4473-4480.
PMID: 31188435 PMC: 6736213. DOI: 10.1210/jc.2019-00705.
A retrospective study of elevated post-operative parathormone in primary hyperparathyroid patients.
Cao S, Hu Y, Zhao Y, Su Z, Xu Z, Gao X Oncotarget. 2017; 8(60):101158-101164.
PMID: 29254153 PMC: 5731863. DOI: 10.18632/oncotarget.20416.